Drug Profile
PM 19
Alternative Names: Polyoxometalase 19Latest Information Update: 22 Nov 2007
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; Terumo
- Class Antivirals
- Mechanism of Action HIV replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections; HIV infections